about
Contemporary evaluation and management of lower extremity peripheral artery disease.Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery.Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program.Incidence, procedural management, and clinical outcomes of coronary in-stent restenosis: Insights from the National VA CART Program.Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.Midterm Outcomes After Endovascular Intervention for Occluded vs Stenosed External Iliac Arteries.Long-term outcomes of carotid artery stenting in patients with a contralateral carotid artery occlusionLong-term outcomes after re-entry device use for recanalization of common iliac artery chronic total occlusionsTemporal trends in the management and clinical outcomes of lower extremity arterial thromboembolism within a national Veteran populationLaser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomesDual antiplatelet therapy in non-ST elevation acute coronary syndromes at Veterans Affairs HospitalsAcute and Midterm Outcomes of Antegrade vs Retrograde Crossing Strategies for Endovascular Treatment of Iliac Artery Chronic Total OcclusionsDevelopment and validation of a predictive score for anterograde crossing of infrapopliteal chronic total occlusions: (The Infrapop-CTO Score)Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal LesionsComparison of rotational and orbital atherectomy for the treatment of calcific coronary lesions: Insights from the VA clinical assessment reporting and tracking (CART) program
P50
Q38850458-ED13ABBA-1500-4A7A-BEA8-9A9B1DBAF915Q40694877-892C28D1-ECDB-4AA4-A500-1B43CF7155A0Q46181511-91C5AB68-B40D-4B15-A64C-58E2FF642CE5Q47843135-3F20BA3B-6F9B-4A2E-827E-986A5AF08265Q48123040-D7D7A862-73F2-484A-B0CA-4910793C0B4AQ48199206-E9A0D964-C8D8-417D-9727-3B64592726FAQ52350820-2C17D704-CC86-4465-AE8F-AE81E04D44AAQ57796299-3C5BFF80-AD19-426F-A7B4-1F921A6C79DDQ88009918-AF529A06-D85C-4599-899D-B5531F28872AQ90935657-2F66A16E-E544-44AF-BDEE-10BCEB20CA30Q91802361-ADD300B1-8AEE-4F98-9615-8D7C6EE9DA30Q92049447-D66ED6D6-590F-481A-A393-04386120D3A0Q92150644-03627987-1923-43CA-9647-57FA99D47C85Q92438753-07D7FE36-EEB7-4B98-AE26-46BA2A2D52A5Q94506271-31BF9609-08E1-4ACD-94DD-B00D806CC93CQ95659896-F07F550E-21A7-4A7A-A062-DA23D13AD2DD
P50
description
researcher
@en
wetenschapper
@nl
name
Stephen W Waldo
@en
Stephen W Waldo
@nl
type
label
Stephen W Waldo
@en
Stephen W Waldo
@nl
prefLabel
Stephen W Waldo
@en
Stephen W Waldo
@nl
P31
P496
0000-0003-0678-4873